These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 21555534)
1. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation. Béziat V; Duffy D; Quoc SN; Le Garff-Tavernier M; Decocq J; Combadière B; Debré P; Vieillard V J Immunol; 2011 Jun; 186(12):6753-61. PubMed ID: 21555534 [TBL] [Abstract][Full Text] [Related]
2. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells. Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217 [TBL] [Abstract][Full Text] [Related]
3. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome. Thum MY; Bhaskaran S; Abdalla HI; Ford B; Sumar N; Shehata H; Bansal AS Hum Reprod; 2004 Oct; 19(10):2395-400. PubMed ID: 15319390 [TBL] [Abstract][Full Text] [Related]
4. The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Vitale M; Della Chiesa M; Carlomagno S; Romagnani C; Thiel A; Moretta L; Moretta A Eur J Immunol; 2004 Jun; 34(6):1715-22. PubMed ID: 15162442 [TBL] [Abstract][Full Text] [Related]
5. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells. Gaddy J; Broxmeyer HE Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743 [TBL] [Abstract][Full Text] [Related]
6. Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation. Tanaka J; Sugita J; Asanuma S; Arita K; Shono Y; Kikutchi M; Shiratori S; Wakasa K; Yasumoto A; Shigematu A; Kondo T; Kobayashi T; Asaka M; Imamura M Hum Immunol; 2009 Sep; 70(9):701-5. PubMed ID: 19524005 [TBL] [Abstract][Full Text] [Related]
7. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering. Ayello J; van de Ven C; Fortino W; Wade-Harris C; Satwani P; Baxi L; Simpson LL; Sanger W; Pickering D; Kurtzberg J; Cairo MS Biol Blood Marrow Transplant; 2006 Jun; 12(6):608-22. PubMed ID: 16737934 [TBL] [Abstract][Full Text] [Related]
8. CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation. Morandi F; Horenstein AL; Chillemi A; Quarona V; Chiesa S; Imperatori A; Zanellato S; Mortara L; Gattorno M; Pistoia V; Malavasi F J Immunol; 2015 Aug; 195(3):965-72. PubMed ID: 26091716 [TBL] [Abstract][Full Text] [Related]
9. Analysis of CD16+dim and CD16+bright lymphocytes--comparison of peripheral and clonal non-MHC-restricted T cells and NK cells. Uciechowski P; Werfel T; Leo R; Gessner JE; Schubert J; Schmidt RE Immunobiology; 1992 Jun; 185(1):28-40. PubMed ID: 1398740 [TBL] [Abstract][Full Text] [Related]
10. Fc gamma RIII activation is different in CD16+ cytotoxic T lymphocytes and natural killer cells. Uciechowski P; Gessner JE; Schindler R; Schmidt RE Eur J Immunol; 1992 Jun; 22(6):1635-8. PubMed ID: 1376268 [TBL] [Abstract][Full Text] [Related]
11. CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells. Márquez ME; Millet C; Stekman H; Conesa A; Deglesne PA; Toro F; Sanctis JD; Blanca I Cell Immunol; 2010; 264(1):86-92. PubMed ID: 20553754 [TBL] [Abstract][Full Text] [Related]
12. CD16+ CD56- NK cells in the peripheral blood of cord blood transplant recipients: a unique subset of NK cells possibly associated with graft-versus-leukemia effect. Lu X; Kondo Y; Takamatsu H; Ohata K; Yamazaki H; Takami A; Akatsuka Y; Nakao S Eur J Haematol; 2008 Jul; 81(1):18-25. PubMed ID: 18363874 [TBL] [Abstract][Full Text] [Related]
13. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56 Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K Front Immunol; 2021; 12():640672. PubMed ID: 34017328 [TBL] [Abstract][Full Text] [Related]
14. Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions. Zhang Y; Zhao A; Wang X; Shi G; Jin H; Lin Q Fertil Steril; 2008 Nov; 90(5):1931-7. PubMed ID: 18023431 [TBL] [Abstract][Full Text] [Related]
15. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin. Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416 [TBL] [Abstract][Full Text] [Related]
16. Natural killer cell lytic activity and CD56(dim) and CD56(bright) cell distributions during and after intensive training. Suzui M; Kawai T; Kimura H; Takeda K; Yagita H; Okumura K; Shek PN; Shephard RJ J Appl Physiol (1985); 2004 Jun; 96(6):2167-73. PubMed ID: 14752119 [TBL] [Abstract][Full Text] [Related]
17. Participation of the CD94 receptor complex in costimulation of human natural killer cells. Voss SD; Daley J; Ritz J; Robertson MJ J Immunol; 1998 Feb; 160(4):1618-26. PubMed ID: 9469418 [TBL] [Abstract][Full Text] [Related]
18. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. Dulphy N; Haas P; Busson M; Belhadj S; Peffault de Latour R; Robin M; Carmagnat M; Loiseau P; Tamouza R; Scieux C; Rabian C; Di Santo JP; Charron D; Janin A; Socié G; Toubert A J Immunol; 2008 Aug; 181(3):2227-37. PubMed ID: 18641363 [TBL] [Abstract][Full Text] [Related]
19. CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells. Vukicevic M; Chalandon Y; Helg C; Matthes T; Dantin C; Huard B; Chizzolini C; Passweg J; Roosnek E Eur J Immunol; 2010 Nov; 40(11):3246-54. PubMed ID: 20957748 [TBL] [Abstract][Full Text] [Related]
20. Immunosenescence of human natural killer cells. Gayoso I; Sanchez-Correa B; Campos C; Alonso C; Pera A; Casado JG; Morgado S; Tarazona R; Solana R J Innate Immun; 2011; 3(4):337-43. PubMed ID: 21576928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]